U.S. Genetic Testing Market Size, Share, Trends & COVID-19 Impact Analysis, By Technique (PCR, DNA Sequencing, Microarrays, and Others), By Application (Cardiology, Oncology, Pharmacogenomics, Cognitive Dysfunction, Pathogenomics, and Others), By Payer (Public Health Insurance, Private Health Insurance, and Out-of-Pocket), By End-User (Hospitals, and Independent Laboratories) & Forecast, 2020-2027

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI105034

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Regulatory Overview
2. Overview: Funding Raised by Genetic Testing focused Start-up Companies
3. Key Industry Developments - Mergers, Acquisitions, and Partnership
4. Porter’s Five Forces Analysis
5. SWOT Analysis
6. Impact of COVID-19 Pandemic on the U.S. Genetic Testing Market
7. Analysis of Transactions in the Molecular Diagnostic Clinical Laboratory Market
8. Overview: Personalized Medicine Market Size (USD billion), U.S., 2019
9. Reimbursement Scenario
U.S. Genetic Testing Market Analysis, Insights and Forecast, 2016-2027
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Technique
  1. PCR
  2. DNA Sequencing
  3. Microarrays
  4. Others
3. Market Analysis, Insights and Forecast – By Application
  1. Cardiology
  2. Oncology
  3. Pharmacogenomics
  4. Cognitive Dysfunction
  5. Pathogenomics
  6. Others
4. Market Analysis, Insights and Forecast – By Payer
  1. Public Health Insurance
  2. Private Health Insurance
  3. Out-of-Pocket
5. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Independent Laboratories
Competitive Analysis
1. U.S. Market Share Analysis (2019)
2. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based On Availability))
  1. Invitae Corporation
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
  2. Ambry Genetics
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
  3. BioReference Laboratories, Inc.
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
  4. Progenity, Inc.
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
  5. PathemaGX
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
  6. Quest Diagnostics Incorporated
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
  7. Myriad Genetics, Inc.
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
  8. Fulgent Genetics
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
  9. Burning Rock Biotech Limited
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)